PHARMACOKINETICS OF SELINEXOR IN COMBINATION WITH CHEMOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA: A PHASE I TRIAL.

被引：0
|
作者：
Badawi, M. [1 ]
Walker, A. [1 ]
Mims, A. [1 ]
Vasu, S. [1 ]
Blum, W. [2 ]
Klisovic, R. [2 ]
Bhatnagar, B. [1 ]
Phelps, M. [1 ]
机构：
[1] Ohio State Univ, Columbus, OH 43210 USA
[2] Emory Univ, Sch Med, Atlanta, GA USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2019年 / 105卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII-032
引用
收藏
页码：S51 / S51
页数：1
相关论文
共 50 条
  • [1] Phase 1 study of selinexor in combination with salvage chemotherapy in Adults with relapsed or refractory Acute myeloid leukemia
    Bhatnagar, Bhavana
    Zhao, Qiuhong
    Mims, Alice S.
    Vasu, Sumithira
    Behbehani, Gregory K.
    Larkin, Karilyn
    Blachly, James S.
    Badawi, Mohamed A.
    Hill, Kasey L.
    Dzwigalski, Kyle R.
    Phelps, Mitch A.
    Blum, William
    Klisovic, Rebecca B.
    Ruppert, Amy S.
    Ranganathan, Parvathi
    Walker, Alison R.
    Garzon, Ramiro
    [J]. LEUKEMIA & LYMPHOMA, 2023, 64 (13) : 2091 - 2100
  • [2] A Phase 1 Clinical Trial of Selinexor in Combination with Decitabine in Patients with Newly Diagnosed and Relapsed or Refractory Acute Myeloid Leukemia
    Bhatnagar, Bhavana
    Klisovic, Rebecca B.
    Walker, Alison R.
    Vasu, Sumithra
    Mims, Alice S.
    Walsh, Katherine J.
    Behbehani, Gregory K.
    Blachly, James S.
    Vittorio, Molly
    Zhao, Qiuhong
    Ruppert, Amy S.
    Orwick, Shelley
    Ranganathan, Parvathi
    Byrd, John C.
    Blum, William
    Garzon, Ramiro
    [J]. BLOOD, 2016, 128 (22)
  • [3] A phase I trial of selinexor plus FLAG-Ida for the treatment of refractory/relapsed adult acute myeloid leukemia patients
    Martinez Sanchez, Maria P.
    Megias-Vericat, Juan Eduardo
    Rodriguez-Veiga, Rebeca
    Vives, Susana
    Bergua, Juan Miguel
    Torrent, Anna
    Suarez-Varela, Sara
    Boluda, Blanca
    Martinez-Lopez, Joaquin
    Cano-Ferri, Isabel
    Acuna-Cruz, Evelyn
    Torres-Minana, Laura
    Martin-Herreros, Beatriz
    Serrano, Alfons
    Sempere, Amparo
    Barragan, Eva
    Sargas, Claudia
    Sanz, Miguel
    Martinez-Cuadron, David
    Montesinos, Pau
    [J]. ANNALS OF HEMATOLOGY, 2021, 100 (06) : 1497 - 1508
  • [4] A phase I trial of selinexor plus FLAG-Ida for the treatment of refractory/relapsed adult acute myeloid leukemia patients
    María P. Martínez Sánchez
    Juan Eduardo Megías-Vericat
    Rebeca Rodríguez-Veiga
    Susana Vives
    Juan Miguel Bergua
    Anna Torrent
    Sara Suárez-Varela
    Blanca Boluda
    Joaquín Martínez-López
    Isabel Cano-Ferri
    Evelyn Acuña-Cruz
    Laura Torres-Miñana
    Beatriz Martín-Herreros
    Alfons Serrano
    Amparo Sempere
    Eva Barragán
    Claudia Sargas
    Miguel Sanz
    David Martínez-Cuadrón
    Pau Montesinos
    [J]. Annals of Hematology, 2021, 100 : 1497 - 1508
  • [5] Preliminary Safety and Efficacy of Venetoclax and Selinexor in Combination with Chemotherapy in Pediatric and Young Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia: Selclax
    Zarnegar-Lumley, Sara
    Karol, Seth E.
    Pounds, Stanley
    Klco, Jeffery M.
    Sulis, Maria Luisa
    Kuo, Dennis John
    Heym, Kenneth Matthew
    Ludwig, Kathleen
    Stevens, Alexandra McLean
    Alexander, Thomas B.
    Faulk, Kelly Elizabeth
    Sabnis, Himalee S.
    Tasian, Sarah K.
    Taub, Jeffrey
    Place, Andrew E.
    Rubnitz, Jeffrey E.
    [J]. BLOOD, 2023, 142
  • [6] A PHASE I TRIAL OF LENALIDOMIDE IN COMBINATION WITH INTERMEDIATE DOSE CYTARABINE (IDC) IN RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (AML) PATIENTS
    Vigil, E.
    Griffiths, A.
    Thompson, E.
    Brady, E.
    Dickey, M.
    Ford, A.
    Wang, S.
    Wetzler, M.
    [J]. HAEMATOLOGICA, 2012, 97 : 33 - 33
  • [7] Gemtuzumab ozogamicin in combination with intensive chemotherapy in relapsed or refractory acute myeloid leukemia
    Chantepie, Sylvain P.
    Reboursiere, Emilie
    Mear, Jean-Baptiste
    Gac, Anne-Claire
    Salaun, Veronique
    Benabed, Khaled
    Cheze, Stephane
    Johnsonansah, Hyacinthe
    Macro, Margaret
    Vilque, Jean-Pierre
    Reman, Oumedaly
    [J]. LEUKEMIA & LYMPHOMA, 2015, 56 (08) : 2326 - 2330
  • [8] A Phase II Trial of Decitabine and Vorinostat in Combination with Chemotherapy for Relapsed/Refractory Acute Lymphoblastic Leukemia
    Burke, Michael J.
    Lamba, Jatinder
    Weigel, Brenda
    Bachanova, Veronika
    Verneris, Michael R.
    Miller, Jeffrey S.
    [J]. BLOOD, 2012, 120 (21)
  • [9] Selinexor combined with cladribine, cytarabine, and filgrastim in relapsed or refractory acute myeloid leukemia
    Abboud, Ramzi
    Chendamarai, Ezhilarasi
    Rettig, Michael P.
    Trinkaus, Kathryn M.
    Riedell, Peter A.
    Abboud, Camille N.
    Ghobadi, Armin
    Pusic, Iskra
    Stockerl-Goldstein, Keith
    Schroeder, Mark A.
    Vij, Ravi
    Westervelt, Peter
    DiPersio, John F.
    Uy, Geoffrey L.
    [J]. HAEMATOLOGICA, 2020, 105 (08) : E404 - E407
  • [10] hase I Study of the Selinexor in Relapsed/Refractory Childhood Acute Leukemia
    Place, Andrew E.
    Blonquist, Traci M.
    Stieglitz, Elliot
    Cooper, Todd M.
    Gore, Lia
    Aplenc, Richard
    Loh, Mignon L.
    Pauly, Melinda
    Rau, Rachel E.
    Burke, Michael J.
    Etchin, Julia
    Look, Thomas
    Sulis, Maria Luisa
    Silverman, Lewis B.
    [J]. BLOOD, 2018, 132
12345